Clinical trial

Renin Profiling in Selection of Initial Antihypertensive Drug

NCT00834600

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-12-01

PhaseNA

Study timeline

Study start (unknown)2005-12-01Date precision: month

Registry last updated2012-04-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Interventions

olmesartan, hydrochlorothiazide, amlodipineDRUG

hydrochlorothiazide (HCTZ) or olmesartanDRUG

Sponsors & collaborators

The Louis & Rachel Rudin Foundationlead sponsor

Daiichi Sankyocollaborator

Mapped research locations

The BronxNew York, United States5

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00834600 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.